logo Kompas.id
EnglishDo not Disregard the...

Do not Disregard the Standardization of Vaccine Research

The Food and Drug Monitoring Agency (BPOM) confirmed that research for the Nusantara vaccine cannot continue onto its second phase as many aspects need to be corrected according to scientific principles.

· 4 minutes read

Head of the Food and Drug Administration (BPOM) Penny K Lukito while checking the Sinovac Covid-19 vaccine storage facility at the Sidoarjo Health Office, East Java, Tuesday (23/2/2021).

BANDUNG, KOMPAS – Controversy regarding the development of the Nusantara vaccine must be resolved immediately so as not to hamper COVID-19 vaccine needs in the country. For optimal results, research standardization should not be ignored.

Food and Drug Monitoring Agency (BPOM) head Penny K. Lukito emphasized, while reviewing the development of the Merah Putih vaccine at Bio Farma, Bandung, West Java, Friday (16/4/2021), that vaccine development must adhere to the existing standards as it concerns human safety.

Syahnan Rangkuti
Logo Kompas
Logo iosLogo android
Kantor Redaksi
Menara Kompas Lantai 5, Jalan Palmerah Selatan 21, Jakarta Pusat, DKI Jakarta, Indonesia, 10270.
+6221 5347 710
+6221 5347 720
+6221 5347 730
+6221 530 2200
Kantor Iklan
Menara Kompas Lantai 2, Jalan Palmerah Selatan 21, Jakarta Pusat, DKI Jakarta, Indonesia, 10270.
+6221 8062 6699
Layanan Pelanggan
Kompas Kring
+6221 2567 6000